Application 020191
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ALOMIDE | LODOXAMIDE TROMETHAMINE | SOLUTION/DROPS;OPHTHALMIC | EQ 0.1% BASE | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0065-0345 | ALOMIDE | lodoxamide tromethamine | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0345 | ALOMIDE | lodoxamide tromethamine | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0345 | ALOMIDE | lodoxamide tromethamine | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0345 | ALOMIDE | lodoxamide tromethamine | Alcon Laboratories, Inc. | NDA | Current |
| 0065-0345 | ALOMIDE | lodoxamide tromethamine | Alcon Laboratories, Inc. | NDA | Current |
| 0078-0736 | ALOMIDE | lodoxamide tromethamine | Novartis Pharmaceuticals Corporation | NDA | Current |